Miniatura

Fitxers

1-s2.0-S021265671730358X-main.pdf (665.46 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2019-06

Llicència de publicació

cc by-nc-nd (c) Morros et al., 2019
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/135500

Neumonías adquiridas en la comunidad en pacientes con enfermedad pulmonar obstructiva crónica tratados con corticoides inhalados u otros broncodilatadores. Estudio PNEUMOCORT

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1016/j.aprim.2018.02.007

Resum

OBJECTIVES: To analyse the risk of pneumonia and/or exacerbations in patients with chronic obstructive pulmonary disease (COPD) who receive treatment with inhaled corticosteroids (CI), in comparison with those who are not treated with inhaled corticosteroids (NCI). To estimate the risk of pneumonia according to CI dose. DESIGN: Population-based cohort study. SETTING: Primary Healthcare. Institut Catala de la Salut. PARTICIPANTS: Patients >/=45 years-old diagnosed with COPD between 2007 and 2009 in the Information System for Research in Primary Care (SIDIAP). INTERVENTION: Two cohorts; patients initiating CI and patients initiating bronchodilators after COPD diagnosis. MAIN MEASUREMENTS: Demographics, smoking, medical history, pneumonias, exacerbations, vaccinations, and drug therapy. RESULTS: A total of 3,837 patients were included, 58% in the CI and 42% in the NCI group. Higher incidence rates of pneumonia and exacerbations were detected in the CI group compared with the NCI (2.18 vs. 1.37). The risk of pneumonia and severe exacerbations was not significantly different between groups, HR; 1.17 (95% CI; 0.87-1.56) and 1.06 (95% CI; 0.87-1.31), respectively. Patients in the CI group had a higher risk of mild exacerbations, HR; 1.28 (95% CI; 1.10-1.50). Variables associated with a higher risk of pneumonia were age, diabetes, previous pneumonias and bronchitis, very severe COPD, treatment with low doses of beta2-adrenergic or anticholinergic agents, and previous treatment with oral corticosteroids. CONCLUSIONS: There were no differences between cohorts in the risk of pneumonia and severe exacerbations. The risk of mild exacerbations was higher in the CI group. Pneumonias and severe exacerbations were more frequent in patients with severe COPD and in patients receiving high doses of CI.

Matèries

Pneumònia adquirida a la comunitat, Malalties pulmonars obstructives cròniques, Broncodilatadors

Matèries (anglès)

Community-acquired pneumonia, Chronic obstructive pulmonary diseases, Bronchodilator agents

Citació

Col·leccions

Articles publicats en revistes (ISGlobal)

Citació

MORROS PEDRÓS, Rosa, VEDIA, Cristina, GINER SORIANO, Maria, CASELLAS, Aina, AMADO, Ester, BAENA DÍEZ, José miguel, PNEUMOCORT. Neumonías adquiridas en la comunidad en pacientes con enfermedad pulmonar obstructiva crónica tratados con corticoides inhalados u otros broncodilatadores. Estudio PNEUMOCORT. _Atención Primaria_. 2019. Vol. 51, núm. 6, pàgs. 333-340. [consulta: 25 de febrer de 2026]. ISSN: 0212-6567. [Disponible a: https://hdl.handle.net/2445/135500]

Exportar metadades

JSON - METS

Compartir registre